Literature DB >> 8960157

Ovarian dysfunction in mice following chromium (VI) exposure.

R C Murthy1, M Junaid, D K Saxena.   

Abstract

Chromium (VI) was given through drinking water in two sets of adult Swiss albino female mice in three doses; 250 ppm, 500 ppm and 750 ppm for 20 days in set 1 and 0.05 ppm, 0.5 ppm and 5.0 ppm in set II for 90 days. At the termination of the treatment, the animals of both the sets were euthanized for histopathology, follicle counting, counting of the superovulated ova, duration of estrus cycle and for ultrastructural studies. Ovaries of the highest dose group (750 ppm) showed large numbers of atretic follicles and congestion in stromal tissue compared to the rest of the treated groups. Also, there was a dose-dependent reduction in the number of follicles at different stages of their maturation. The number of ova recovered from superovulated chromium (VI)-treated animals showed significant decreases in the 500 and 750 ppm dosed groups compared to lower dosed (250 ppm) and control groups. The duration of estrus cycle increased in highest dosed (750 ppm) group. A dose-dependent increase in blood chromium level was also seen in treated mice. Ultrastructural observations revealed disintegrated cell membranes of two layered follicular cells and altered villiform mitochondria in thecal cells of 5 ppm dosed group. From the study it was concluded that ovarian physiology and rate of ovulation might be altered if females are exposed to sufficiently high chromium through oral route.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8960157     DOI: 10.1016/s0378-4274(96)03803-9

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  The effects on bone cells of metal ions released from orthopaedic implants. A review.

Authors:  Valerio Sansone; Davide Pagani; Marco Melato
Journal:  Clin Cases Miner Bone Metab       Date:  2013-01

Review 2.  Roles of reactive oxygen species and antioxidants in ovarian toxicity.

Authors:  Patrick J Devine; Sally D Perreault; Ulrike Luderer
Journal:  Biol Reprod       Date:  2012-02-09       Impact factor: 4.285

3.  Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women.

Authors:  Kristen Upson; Helen B Chin; Erica E Marsh; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2019-01-14       Impact factor: 2.681

4.  Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors.

Authors:  Jone A Stanley; JeHoon Lee; Thamizh K Nithy; Joe A Arosh; Robert C Burghardt; Sakhila K Banu
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

5.  Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53.

Authors:  Sakhila K Banu; Jone A Stanley; Jehoon Lee; Sam D Stephen; Joe A Arosh; Patricia B Hoyer; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-22       Impact factor: 4.219

6.  Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.

Authors:  Chad M Thompson; Christopher R Kirman; Sean M Hays; Mina Suh; Seneca E Harvey; Deborah M Proctor; Julia E Rager; Laurie C Haws; Mark A Harris
Journal:  J Appl Toxicol       Date:  2017-10-24       Impact factor: 3.446

7.  Direct embryotoxicity of chromium (III) exposure during preimplantation development.

Authors:  Yuhe Tian; Qisheng Zhu; Jiayu Yuan; Robert Kneepkens; Yuan Yue; Chao Zhang
Journal:  J Reprod Dev       Date:  2021-07-18       Impact factor: 2.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.